Max Healthcare Institute Management

Management Kriterienprüfungen 2/4

Max Healthcare Institute CEO ist Abhay Soi , ernannt in Jun 2020, hat eine Amtszeit von 4.42 Jahren. Die jährliche Gesamtvergütung beträgt ₹247.33M , bestehend aus 79.7% Gehalt und 20.3% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 23.74% der Aktien des Unternehmens, im Wert von ₹230.73B . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5.1 Jahre bzw. 3.5 Jahre.

Wichtige Informationen

Abhay Soi

Geschäftsführender

₹247.3m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	79.7%
Amtszeit als Geschäftsführer	4.4yrs
Eigentum des Geschäftsführers	23.7%
Durchschnittliche Amtszeit des Managements	5.1yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	3.5yrs

Jüngste Management Updates

Recent updates

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Abhay Soi im Vergleich zu den Einnahmen von Max Healthcare Institute verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Sep 30 2024	n/a	n/a	₹11b
Jun 30 2024	n/a	n/a	₹11b
Mar 31 2024	₹247m	₹197m	₹11b
Dec 31 2023	n/a	n/a	₹11b
Sep 30 2023	n/a	n/a	₹10b
Jun 30 2023	n/a	n/a	₹12b
Mar 31 2023	₹140m	₹140m	₹11b
Dec 31 2022	n/a	n/a	₹10b
Sep 30 2022	n/a	n/a	₹9b
Jun 30 2022	n/a	n/a	₹6b
Mar 31 2022	₹140m	₹49m	₹6b
Dec 31 2021	n/a	n/a	₹6b
Sep 30 2021	n/a	n/a	₹5b
Jun 30 2021	n/a	n/a	₹3b
Mar 31 2021	₹117m	₹91m	-₹1b

Vergütung im Vergleich zum Markt: AbhayDie Gesamtvergütung ($USD2.93M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Indian ($USD1.10M).

Entschädigung vs. Einkommen: AbhayDie Bezüge der Mitarbeiter sind im vergangenen Jahr um mehr als 20 % gestiegen.

Geschäftsführer

Abhay Soi (51 yo)

4.4yrs

Amtszeit

₹247,330,308

Vergütung

Mr. Abhay Soi is a Co-Founder of Halcyon Group. He served as Executive Officer at Ernst & Young LLP. Mr. Soi served as Head of Financial Restructuring group at Ernst & Young and Arthur Anderson.He has in-...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Abhay Soi	Chairman & MD	4.4yrs	₹247.33m	23.74% ₹ 230.7b
Yogesh Sareen	Senior Director & CFO	12.8yrs	₹45.10m	0.0062% ₹ 60.0m
Dhiraj Aroraa	Senior VP	1.8yrs	₹10.00m	keine Daten
Mradul Kaushik	Member of Group Medical Advisory Council	no data	keine Daten	keine Daten
Prashant Singh	Director of Information Technology & Chief Information Officer	5.2yrs	keine Daten	keine Daten
Gagan Palta	General Counsel & Director	less than a year	keine Daten	keine Daten
Anas Wajid	Senior Director and Chief Sales & Marketing Officer	no data	keine Daten	keine Daten
Umesh Gupta	Member of Group Medical Advisory Council	5.3yrs	keine Daten	keine Daten
Sandeep Budhiraja	Member of Group Medical Advisory Council & Group Medical Director	no data	keine Daten	keine Daten
Sanjiv K. Marya	Member of Group Medical Advisory Council	5.1yrs	keine Daten	keine Daten
Anurag Krishna	Chairman of Paediatrics & Paediatric Surgery	3.8yrs	keine Daten	keine Daten
Harinder Chehal	Senior Director & COO - Cluster 2	5.3yrs	keine Daten	keine Daten

5.1yrs

Durchschnittliche Betriebszugehörigkeit

54yo

Durchschnittliches Alter

Erfahrenes Management: 543220Das Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (5.1 ).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Abhay Soi	Chairman & MD	5.4yrs	₹247.33m	23.74% ₹ 230.7b
Mradul Kaushik	Member of Group Medical Advisory Council	no data	keine Daten	keine Daten
Gagan Palta	General Counsel & Director	less than a year	keine Daten	keine Daten
Umesh Gupta	Member of Group Medical Advisory Council	no data	keine Daten	keine Daten
Sandeep Budhiraja	Member of Group Medical Advisory Council & Group Medical Director	no data	keine Daten	keine Daten
Sanjiv K. Marya	Member of Group Medical Advisory Council	no data	keine Daten	keine Daten
N. Venkatesan	Director & Chief Procurement Officer	no data	keine Daten	keine Daten
Mahendra Lodha	Non-Executive Independent Director	5.4yrs	₹5.25m	keine Daten
Narayan Seshadri	Non-Executive Non-Independent Director	1.5yrs	₹3.83m	keine Daten
Pradeep Chowbey	Member of Group Medical Advisory Council	no data	₹4.42m	keine Daten
Harit Chaturvedi	Member of Group Medical Advisory Council	no data	keine Daten	keine Daten
Dinesh Khullar	Member of Group Medical Advisory Council	no data	keine Daten	keine Daten

3.5yrs

Durchschnittliche Betriebszugehörigkeit

57.5yo

Durchschnittliches Alter

Erfahrener Vorstand: 543220Die Vorstandsmitglieder gelten als erfahren (3.5 Jahre durchschnittliche Amtszeit).

Max Healthcare Institute Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jüngste Management Updates

Max Healthcare Institute Limited Cessation of Gautam Wadhwa as Director

Max Healthcare Institute Limited Appoints Kummamuri Narasimha Murthy as an Independent Director

Insufficient new directors

Max Healthcare Institute Limited, Annual General Meeting, Sep 20, 2024

Max Healthcare Institute Limited Announces Change in Management

Max Healthcare Institute Limited, Annual General Meeting, Sep 27, 2023

Recent updates

Consensus revenue estimates increase by 13%

Max Healthcare Institute Limited (BSE:543220) acquired remaining 36.35% stake in Jaypee Healthcare Limited from Lakshdeep Investments & Finance Pvt. Ltd and Lakshdeep Infrastructure and Holding Private Limited for INR 2.3 billion.

Price target increased by 8.2% to ₹1,017

Second quarter 2025 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited Cessation of Gautam Wadhwa as Director

Max Healthcare Institute Limited (BSE:543220) completed the acquisition of 63.65% stake in Jaypee Healthcare Limited from Lakshdeep Investments & Finance Pvt. Ltd and Lakshdeep Infrastructure and Holding Private Limited for INR 4 billion.

Max Healthcare Institute Limited Appoints Kummamuri Narasimha Murthy as an Independent Director

Max Healthcare Institute Limited Announces Declaration of Final Dividend

Max Healthcare Institute Limited (BSE:543220) entered into a Strategic Collaboration Agreement to acquire 64% stake in Jaypee Healthcare Limited from Lakshdeep Investments & Finance Pvt. Ltd and Lakshdeep Infrastructure and Holding Private Limited for an enterprise value of INR 16.6 billion.

Insufficient new directors

Max Healthcare Institute Limited to Report Q2, 2025 Results on Nov 06, 2024

Upcoming dividend of ₹1.50 per share

Max Healthcare Institute Limited, Annual General Meeting, Sep 20, 2024

First quarter 2025 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q1, 2025 Results on Aug 01, 2024

Max Healthcare Institute Limited Recommends Final Dividend for the Financial Year 2023-24

Full year 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q4, 2024 Results on May 22, 2024

Max Healthcare Institute Limited (BSE:543220) agreed to acquire Alexis Multi-speciality Hospital Private Limited for approximately INR 3720 million.

Price target increased by 11% to ₹767

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Nine Months, 2024 Results on Jan 31, 2024

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q2, 2024 Results on Nov 06, 2023

Max Healthcare Institute Limited Approves the Declaration of Final Dividend for the Financial Year Ended March 31, 2023

Max Healthcare Institute Limited Announces Change in Management

Max Healthcare Institute Limited Provides Update on Petition Filed by the Company Against Touch Healthcare Private Limited and Others

Max Healthcare Institute Limited, Annual General Meeting, Sep 27, 2023

Max Healthcare Institute Limited Announces Appointment of Amrita Gangotra as Additional Director (Non-Executive and Independent Woman Director)

Price target increased by 7.1% to ₹611

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q1, 2024 Results on Aug 07, 2023

Aster Eye $300 million India Stake Sale

Price target increased by 8.1% to ₹564

Full year 2023 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q4, 2023 Results on May 16, 2023

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates increase by 12%

Max Healthcare Institute Limited Announces Executive Changes

Max Healthcare Institute Limited to Report Q3, 2023 Results on Feb 02, 2023

Blackstone, CVC Manipal, Max Reportedly Eye KIMS Stake

Max Healthcare Reportedly Eyeing AMRI Hospitals

Price target increased to ₹512

Price target increased to ₹498

KKR, Temasek Reportedly Vie for Care Hospitals; Deal Likely at $1 Billion

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Max Healthcare Institute Limited Announces Management Changes

Max Healthcare Institute Limited to Report Q2, 2023 Results on Nov 01, 2022

Max Healthcare Institute Limited Announces Resignation of Ruchi Mahajan as Company Secretary and Compliance Officer

Max Healthcare Institute Limited Announces Cessation of Prashant Kumar as Non-Executive Non-Independent Director

Investor sentiment improved over the past week

Max Healthcare Institute Limited Announces Resignation of Gaurav Trehan as Non-Executive Non-Independent Director

KKR Reportedly Plans to Exit Max Healthcare by Selling its Entire 27.54% Stake

Max Healthcare Institute Limited, Annual General Meeting, Sep 26, 2022

High number of new directors

Max Healthcare Institute Limited to Report Q1, 2023 Results on Aug 10, 2022

KKR Affiliate Not in Talks for Stake Sale in Max Health

KKR Reportedly May Sell Stake in Max

Full year 2022 earnings: EPS and revenues miss analyst expectations

Ontario Teachers' Pension Plan Board, Max Healthcare Reportedly Lead the Race for Sahyadri Hospitals

Ontario Teachers' Pension Plan Board, Max Healthcare Reportedly Lead the Race for Sahyadri Hospitals

Max Healthcare Institute Limited to Report Q4, 2022 Results on May 25, 2022

High number of new and inexperienced directors

High number of new directors

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited Announces Executive Changes

Max Healthcare Institute Limited to Report Q3, 2022 Results on Feb 12, 2022

Consensus forecasts updated

Price target increased to ₹444